Unlock stock picks and a broker-level newsfeed that powers Wall Street.
19.93
-0.24
(-1.18%)
As of 11:13:44 AM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -3.09 | -2.68 | -11.89 | -4.67 |
| Low Estimate | -3.09 | -2.68 | -11.89 | -4.67 |
| High Estimate | -3.09 | -2.68 | -11.89 | -4.67 |
| Year Ago EPS | -576 | -464.22 | -108.41 | -11.89 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 2 |
| Avg. Estimate | 2.6M | 2.8M | 11.1M | 98.8M |
| Low Estimate | 2.6M | 2.8M | 11.1M | 31.5M |
| High Estimate | 2.6M | 2.8M | 11.1M | 166.1M |
| Year Ago Sales | 2.48M | 2.21M | 10.09M | 11.1M |
| Sales Growth (year/est) | 4.75% | 26.81% | 9.97% | 790.09% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1,136 | -720 | -736 | -- |
| EPS Actual | -576 | -464.22 | -25.56 | -10.18 |
| Difference | 560 | 255.78 | 710.44 | -- |
| Surprise % | 49.30% | 35.53% | 96.53% | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -3.09 | -2.68 | -11.89 | -4.67 |
| 7 Days Ago | -640 | -672 | -2,784 | 0 |
| 30 Days Ago | -640 | -672 | -2,784 | 0 |
| 60 Days Ago | -640 | -672 | -2,784 | 0 |
| 90 Days Ago | -640 | -672 | -2,784 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TNXP | 99.46% | 99.42% | 89.03% | 60.72% |
| S&P 500 | 16.20% | 6.69% | 10.00% | 14.33% |
Upgrades & Downgrades
| Reiterates | Noble Capital Markets: Outperform to Outperform | 3/20/2025 |
| Maintains | Alliance Global Partners: Buy to Buy | 7/22/2024 |
| Initiated | Dawson James: Buy | 2/28/2024 |
| Maintains | Alliance Global Partners: Buy to Buy | 8/1/2023 |
| Maintains | Alliance Global Partners: Buy to Buy | 6/2/2023 |
| Maintains | Alliance Global Partners: Buy to Buy | 8/31/2021 |
Related Tickers
SLNO Soleno Therapeutics, Inc.
73.25
+1.75%
PRTG Portage Biotech Inc.
8.47
-11.77%
LXRX Lexicon Pharmaceuticals, Inc.
0.5725
+0.35%
OCEA Ocean Biomedical, Inc.
0.0551
-13.39%
OSRH OSR Holdings, Inc.
2.0200
-15.83%
RNAZ TransCode Therapeutics, Inc.
0.5400
+10.20%
SAVA Cassava Sciences, Inc.
1.5650
-5.15%
PSTV Plus Therapeutics, Inc.
0.9946
-14.26%
DRMA Dermata Therapeutics, Inc.
1.1600
-1.69%
MIST Milestone Pharmaceuticals Inc.
0.7918
-10.02%